RHS
Click for more information
0.00% 27.5¢ rhs limited

Ann: Further positive DOPlify benchmarking study published, page-2

  1. bevter
    25,726 Posts.
    lightbulb Created with Sketch. 1245
    clock Created with Sketch.
    12/12/17
    11:23
    Post #: 29561849
    Ticking boxes. One day the mkt will notice.
    "Second Ghent study demonstrates DOPlify™ suitability for liquid biopsy applications Highlights  Second University of Ghent study published demonstrating DOPlify™ is internationally competitive for cell-based liquid biopsy applications  New results reinforce the earlier Ghent study published in July 2017 that DOPlify™ is a world leading Whole Genome Amplification kit
    RHS Price at posting: 14.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

WGX Mining start at South Junction adds to Westgold's hopes for WA gold complex
right-arrow Created with Sketch.
TPG ACCC says no issue with TPG Telecom and Optus Mobile sharing regional networks; spectrum
right-arrow Created with Sketch.
NEWS ASX explains: How 'futures' are predicted
right-arrow Created with Sketch.
GED Golden Deeps sniffs 80-metre-long copper and zinc sulphide zone at NSW's Havilah
right-arrow Created with Sketch.
EBR EBR Systems’ heart pacing device on-target to reach the US market
right-arrow Created with Sketch.
GBR Great Boulder hits fresh gold finds to the north of Mulga Bill in Meekatharra, WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RHS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.